Envarsus XR 1 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DB25FJN38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,718
Award facts
- Contract value 100% obligated
- $1,718.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Envarsus XR 1 mg tablets in a quantity of 100 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,718.48 with firm fixed pricing and is scheduled for completion by September 11, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying a broad range of medications, vaccines, and medical devices to military and veteran healthcare systems. The company's extensive federal contract portfolio with the Defense Logistics Agency demonstrates its capability to fulfill competitive procurement requirements across multiple therapeutic domains. This particular delivery order for Envarsus XR, an immunosuppressant medication used in transplant patients, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with specialized pharmaceutical products essential to military medical operations worldwide.
Quick answers
Who was awarded contract SPE2DB25FJN38?
SPE2DB25FJN38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FJN38 worth?
The government has obligated $1,718 on SPE2DB25FJN38.
Is contract SPE2DB25FJN38 an order under another contract?
Yes. SPE2DB25FJN38 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJN38 competed?
The extent of competition for SPE2DB25FJN38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award